The clinical relevance is straightforward
Athletes caught using it face severe penalties, including suspension and tarnishing of their professional reputations
Administration and Guidance BPC-157 is administered via subcutaneous injection, typically near the area of injury or concern
Approval is a separate pathway entirely, in which a sponsor submits clinical evidence for a specific finished product and FDA determines it is safe and effective for a specific use
Unfortunately, a phase II clinical trial of UBX0101 (NCT03513016) was completed in patients with osteoarthritis and the promising results observed (Table 1), in vitro and in vivo, have not been up to the expectations in treated patients, leading only to a decrease of pain, without a significant improvement of the disease 30
Synergistic effects on appetite suppression and satiety 1-3